| 查看: 1363 | 回复: 13 | |||
[交流]
美国 University of Nebraska-Lincoln 全奖招博士研究生 (Biomedical area)
|
|
Dr. Jiujiu Yu from the Department of Nutrition and Health Sciences at the University of Nebraska Lincoln is recruiting a highly-motivated Ph.D. student for Fall 2022. Our broad research interests are to 1) investigate the molecular mechanisms of NLRP3 inflammasome activation in the innate immune cells; 2) study the role of NLRP3 inflammasome-mediated chronic inflammation in obesity, aging, and liver diseases; and 3) identify new molecular nutraceuticals to suppress such inflammation (https://cehs.unl.edu/nhs/yu-lab/). Minimum qualification includes an M.S. or equivalent degree in biology, biochemistry, nutrition, or related field. Previous research experience in one or more of the following areas (obesity, liver diseases, extracellular vesicles, dietary molecules, mouse models, microbiome) is highly desirable. If interested, please submit your CV and personal statement to Dr. Yu at jyu18@unl.edu please indicate your GPA, TOEFL, and GRE scores in your application. Your application will not be considered without a personal statement or the aforementioned scores. Department requirement: Grade point average of 3.0 or higher on a 4.0 scale. Preferred minimum GRE scores: 145 Verbal; 150 Quantitative; 3.0 Analytical (writing). Required minimum TOEFL score (International students only): 550 paper; 79 internet; or 6.5 IELTS. https://cehs.unl.edu/nhs/graduate-programs/#tab0 |
» 猜你喜欢
281电子信息求调剂
已经有7人回复
材料277分求调剂
已经有7人回复
求调剂院校
已经有12人回复
293求调剂
已经有3人回复
化学 0703求调剂 总分293 一志愿211
已经有10人回复
320材料一志愿西工大专硕英二数二 有两年光伏工作经验
已经有7人回复
材料328求调剂
已经有8人回复
欢迎211本科同学,过A区国家线,A区非偏远一本,交叉学科课题组
已经有10人回复
304分材料专硕求调剂
已经有12人回复
没有青基直接申请面上,感觉自己疯了
已经有12人回复
蝉123456
新虫 (知名作家)
- 应助: 0 (幼儿园)
- 金币: 8614.2
- 散金: 7570
- 沙发: 17
- 帖子: 8491
- 在线: 80.3小时
- 虫号: 25711072
- 注册: 2021-03-08
- 专业: 计算机软件
2楼2022-02-03 19:32:33
3楼2022-02-05 06:09:36
4楼2022-02-06 11:46:10
5楼2022-02-07 01:41:04
6楼2022-02-09 03:10:13
7楼2022-02-10 03:58:07
8楼2022-02-10 23:34:59
9楼2022-02-12 00:00:36
10楼2022-02-13 08:50:05













回复此楼